MSD Switzerland

About MSD Switzerland

At MSD Merck Sharp & Dohme we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. MSD's success story in Switzerland began in 1963. Headquartered in Lucerne, we employ about 1,000 people at five sites in the cantons of Lucerne and Zurich. Our main therapeutic areas are oncology, infectious diseases, cardiovascular, immunology and diabetes. We also have a broad portfolio of vaccines. Switzerland holds a special place in MSD’s global footprint, serving as a key center of excellence for our research, development, manufacturing, and commercialization as well as for our finance, market access and distribution activities.